BioStatus is passionate about cell-based science. We are committed to providing our customers with highly innovative tools, that offer significant advantages to both routine and research-oriented, cell-based analysis. Our mission is to invent, develop and market novel reagents for use in cell-based research, drug screening and healthcare diagnostics and to expand these markets through the development of complementary detection and screening technologies At BioStatus the customer comes first. We are innovation led and undertake objective reviews of all that we do.
Looking for a particular BioStatus Limited employee's phone or email?
The BioStatus Limited annual revenue was $811000 in 2026.
Stefan Ogrodzinski is the Director and CEO of BioStatus Limited.
5 people are employed at BioStatus Limited.
The NAICS codes for BioStatus Limited are [541, 54171, 541713, 5417, 54].
The SIC codes for BioStatus Limited are [87, 873].